Jacobson Pharma files board, committee member list with disclosure responsibilities

• Jacobson Pharma released an updated board and committee roster dated Aug. 11, 2026, detailing directors’ committee roles with disclosure responsibilities.
• Derek Sum Kwong Yip remains chairman, chief executive officer, executive director, executive committee chair.
• Independent directors lead key oversight: Wong Tze Hang chairs audit; Alan Lam Kwing Tong chairs remuneration; Alan Luk Ting Lung chairs nomination.
• Executive committee members include Chun Leung Yim, Yue Wai Pun, Chun Leung Yim, Yue Wai Pun, with Yim also on the ESG committee.
• ESG committee is chaired by Alan Luk; membership includes Chun Leung Yim; company secretary Yu Chun Kau also serves on the committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobson Pharma Corporation Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260811-12280267), on August 11, 2026, and is solely responsible for the information contained therein.